---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-047242"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2026-10-15T20:15:36+00:00"
generated_at: "2026-10-15T20:16:05.503948+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics abandons annual meeting after 4 failed quorum attempts; plans special meeting

## Summary
- Annual Meeting held September 3, 2026 lacked a quorum; reconvened September 24, September 30 and October 14, 2026 with no quorum on any date.
- Company determined not to adjourn again; no business was transacted and none of the meeting's proposals were voted on.
- Co-Diagnostics intends to seek stockholder approval of those proposals at a special meeting on a future, still-unannounced date.
- Date, time and location of any special meeting will be disclosed in proxy materials filed with the SEC and sent to stockholders.
- Signed by CEO Dwight Egan on October 15, 2026; common stock (CODX) trades on the Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-26-047242
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2026-10-15T20:15:36+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315226047242/0001493152-26-047242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315226047242/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-047242
- JSON: https://secwatch.observer/filing/0001493152-26-047242.json
- Plain text: https://secwatch.observer/filing/0001493152-26-047242.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.